Drugmakers' deal making will plow ahead despite antitrust scrutiny, analysts say

2 Biotech Stocks For Your June 2023 Watchlist

Eli Lilly to acquire Dice Therapeutics for $2.4 billion in autoimmune treatment push

Eli Lilly to Buy Dice Therapeutics in $2.4 Billion Autoimmune Disease Push

Dice Therapeutics rallies as it agrees to be bought by Lilly

Eli Lilly to buy Dice Therapeutics in $2.4 billion deal